Records containing: Neuroendocrine Tumors

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2016-01-05
Phase II Study of Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2015-11-20
A Phase II Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
CLINICAL_TRIALS study record update · 2015-11-17
B-Receptor Signaling in Cardiomyopathy
CLINICAL_TRIALS study record update · 2015-09-03
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
CLINICAL_TRIALS study record update · 2015-08-07
Phase II Study of [90Y-DOTA]-TOC and [177Lu-DOTA]-TOC in Metastasized Neuroendocrine Tumors
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2015-04-30
A Multicenter Phase II Open Study Coupled With a Translational Assessment of Biomarkers Predictive of Response to Sunitinib in Patients With Poorly-differentiated Advanced/Inoperable NEURO-Endocrine Tumors.
CLINICAL_TRIALS study record update · 2014-12-22
Safety Profile Assessment of TheraSphere® Yttrium-90 Glass Microspheres Used for Treatment of Metastatic Liver Disease From Primary Colorectal, Neuroendocrine, Cholangiocarcinoma, Melanoma, and Breast Cancers Refractory to Chemotherapy: A Pilot Study
CLINICAL_TRIALS study record update · 2014-09-22
A Randomized Clinical Trial With a New Needle Device Comparing 25G and 22G Needle in Endoscopic Ultrasound Fine-needle Aspiration of Solid Lesions.
CLINICAL_TRIALS study record update · 2013-12-10
A Phase II Study of Capecitabine, Oxaliplatin and Bevacizumab for Metastatic or Unresectable Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2013-08-29
The Feasibility of Novel 124I-MIBG Tracer in Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. Comparison With 123I-MIBG.
CLINICAL_TRIALS study record update · 2013-04-09
A Phase II Study of Bevacizumab in Combination With Temozolomide in Patients With Advanced Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2012-11-21
Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG-Nanodosing: the Path to Higher Sensitivity and Lower Toxicity Radiopharmaceuticals
CLINICAL_TRIALS study record update · 2012-04-03
89Zr-bevacizumab PET Imaging as Predictive Biomarker for Everolimus Efficacy in Patients With Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2011-06-15
A Phase 2, Multi-Center, Open Label Study Evaluating the Efficacy and Safety of Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
CLINICAL_TRIALS study record update · 2011-03-28
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
CLINICAL_TRIALS study record update · 2010-09-23
Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2010-08-12
A Phase II Study of Pemetrexed in Patients With Advanced Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2010-08-04
A Phase Ib, Open-label Study to Evaluate RAD001 as Monotherapy Treatment in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
CLINICAL_TRIALS study record update · 2010-06-03
Evaluation of Serological Markers ProGRP, CgA, NSE and TUM2-PK in Patients With Malignant Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2009-08-06
Continuous 5-fluorouracil Infusion Plus Long Acting Octreotide in Advanced Well Differentiated Neuroendocrine Carcinomas. A Phase II Trial of the Piemonte Oncology Network.
CLINICAL_TRIALS study record update · 2008-07-21
A Phase II Study Of The Efficacy And Safety Of SU011248 In Patients With Advanced Unresectable Neuroendocrine Tumor
CLINICAL_TRIALS study record update · 2008-06-02
ClinicalTrials.gov study NCT00687778